CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Concurrent and Adjuvant Temozolomide for Newly Diagnosed Grade III Gliomas without 1p/19q Co-deletion: A Randomized, Open-Label, Phase 2 Study (KNOG-1101 Study)

Kihwan Hwang, Tae Min Kim, Chul-Kee Park, Jong Hee Chang, Tae-Young Jung, Jin Hee Kim, Do-Hyun Nam, Se-Hyuk Kim, Heon Yoo, Yong-Kil Hong, Eun-Young Kim, Dong-Eun Lee, Jungnam Joo, Yu Jung Kim, Gheeyoung Choe, Byung Se Choi, Seok-Gu Kang, Jeong Hoon Kim, Chae-Yong Kim

Cancer Research and Treatment. 2020;52(2):505-515. Published online 2019 October 28 DOI: https://doi.org/10.4143/crt.2019.421

ACTR-50. EFFECT OF CONCURRENT AND ADJUVANT TEMOZOLOMIDE ON SURVIVAL IN PATIENTS WITH NEWLY DIAGNOSED GRADE III GLIOMAS WITHOUT 1p/19q CO-DELETION: A RANDOMIZED, OPEN-LABEL, PHASE 2 STUDY (INTERIM RESULTS FROM THE KNOG-1101 STUDY)

Chae-Yong Kim, Kihwan Hwang, Tae Min Kim, Chul-Kee Park, Jong Hee Chang, Tae-Young Jung, Dong-Eun Lee, Jungnam Joo, Ghee Young Choe, Yu Jung Kim, Byung Se Choi, Jeong Hoon Kim

Neuro-Oncology. 2018;20(suppl_6):vi23-vi23

Link1

Concurrent and Adjuvant Temozolomide for Newly Diagnosed Grade III Gliomas without 1p/19q Co-deletion: A Randomized, Open-Label, Phase 2 Study (KNOG-1101 Study)

Cancer Research and Treatment. 2020;52(2):505-515

Link1

Link2 Link3

Phase I, open-label, multicentre study of buparlisib in combination with temozolomide or with concomitant radiation therapy and temozolomide in patients with newly diagnosed glioblastoma

Patrick Yung Wen, Jordi A Rodon, Warren Mason, Joseph T Beck, John DeGroot, Valerie Donnet, David Mills, Mona El-Hashimy, Mark Rosenthal

ESMO Open. 2020;5(4):e000673

Link1

Phase 1 dose escalation trial of the safety and pharmacokinetics of cabozantinib concurrent with temozolomide and radiotherapy or temozolomide after radiotherapy in newly diagnosed patients with high-grade gliomas

David Schiff, Annick Desjardins, Timothy Cloughesy, Thomas Mikkelsen, Michael Glantz, Marc C. Chamberlain, David A. Reardon, Patrick Y. Wen

Cancer. 2015;122(4):582-587

Link1 Link2

Surgical management of 1p/19q co-deleted oligodendrogliomas WHO grade II and III

Niklas Thon, Friedrich-Wilhelm Kreth, Joerg-Christian Tonn

Oligodendroglioma. 2019;209-218

Link1 Link2

Interim Results of a Phase II Study of Hypofractionated Radiotherapy with Concurrent Temozolomide Followed by Adjuvant Temozolomide in Patients over 70 Years Old with Newly Diagnosed Glioblastoma

Mehran Yusuf, Beatrice Ugiliweneza, Mark Amsbaugh, Maxwell Boakye, Brian Williams, Megan Nelson, Eyas M. Hattab, Shiao Woo, Eric Burton

Oncology. 2018;95(1):39-42

Link1 Link2

PO-0633: Randomized study of adjuvant temozolomide (6 vs.12 cycle) in newly diagnosed glioblastoma multiforme

A.K. Gandhi, M. Bhandari, D.N. Sharma, P. Julka, G.K. Rath

Radiotherapy and Oncology. 2017;123:S331

Link1 Link2

The Outcomes of Concomitant Chemoradiotherapy Followed by Adjuvant Chemotherapy with Temozolomide for Newly Diagnosed High Grade Gliomas : The Preliminary Results of Single Center Prospective Study

Jung-Won Choi, Min Mi Lee, In Ah Kim, Jee Hyun Kim, Gheeyoung Choe, Chae-Yong Kim

Journal of Korean Neurosurgical Society. 2008;44(4):222

Link1

Phase III, Open-Label, Randomized Study Comparing Concurrent Gemcitabine Plus Cisplatin and Radiation Followed by Adjuvant Gemcitabine and Cisplatin Versus Concurrent Cisplatin and Radiation in Patients With Stage IIB to IVA Carcinoma of the Cervix

J.T. Thigpen

Yearbook of Medicine. 2011;2011:153-154

Link1 Link2

J.T. Thigpen

Yearbook of Oncology. 2011;2011:94-95

Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.